Avoidance of routine use for patients before or after intravitreal injection

NQF Endorsement Status Not Endorsed

NQF ID 9999

Measure Type Process

Measure Content Last Updated 2021-06-30

Info As Of Not Available

Properties

Description The percentage of patients, aged 18 and older, who received topical or systemic before or after intravitreal injections

Numerator Patients who received antibiotics before or after intravitreal injections (same day)

Denominator Patients aged 18 or older who received intravitreal injections, except for

Denominator Exclusions Eyes with endophthalmitis

Rationale The routine use of antibiotics before or after intravitreal injections is unnecessary because research has shown that topical antibiotics don t prevent the occurrence of eye infection. The risks of antibiotic eye drops include allergic reactions. The overuse and repeated exposure to antibiotics can lead to the emergence of bacteria that don t respond readily to available treatments. Routine antisepsis is appropriate and important for prevention of eye infection. Choosing wisely guidelines, preferred practice patterns published by the American Academy of and peer reviewed evidence show that routine antibiotic use in patients before or after intravitreal injections should be avoided. American Academy of Ophthalmology, Practicing Ophthalmologists Learning System. Intravitreal injections [Internet]. San Francisco: American Academy of Ophthalmology, 2008 Nov. [cited 2012 Sep 28]; Available from: one.aao.org/CE/PracticeGuidelines/ClinicalStatements_Content.aspx cid=404813e9-b3dc-4d6d-a2c5-d1f1e78a926b#section4.

Report Generated: Wed Sep 29 23:15:41 EDT 2021 | Page 1

Avoidance of routine antibiotic use for patients before or after intravitreal injection

Bhavsar AR, Googe JM, Stockdale CR Bressler NM, Brucker AJ, Elman MJ, Glassman AR. Clinical Research Network. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required. The Diabetic Retinopathy Clinical Research Network Laser- -Triamcinolone Clinical trials. Arch Ophthalmol [Internet]. 2009 Dec;127(12):1581-3.

Scott IU, Flynn HW. The role of topical antibiotic prophylaxis for intravitreal injections. Arch Ophthalmol [Internet]. 2007 Jul;125(7):974-6.

Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: Effect on endophthalmitis rate [Internet]. . 2011 Nov;31(10):2032-6.

Kim SJ, Toma HS, Midha, Cherney EF, Recchia FM, Doherty TJ. Antibiotic resistance of and nasopharynx evaluation study: A prospective study of patients undergoing intravitreal injections. Ophthalmol [Internet]. 2010 Dec(12):117-2372-8.

Kim SJ, Toma KS. Ophthalmic antibiotics and resistance. A randomized, controlled study of patients undergoing intravitreal injections. Ophthalmol [Internet]. 2011 Jul(7);118:1358 1363.

Cheung CSY; Wong AWT, Kertes PJ, Devenyi RG, Lam WC. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmol [Internet]. 2012 Aug:119(8):1609-14.

Milder E, Vander J, Shah C, Garg S. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injections. Ophthalmol [Internet]. 2012 Jul:119(7):1420-4.

Evidence Not Available

Report Generated: Wed Sep 29 23:15:41 EDT 2021 | Page 2

Avoidance of routine antibiotic use for patients before or after intravitreal injection

Developer/Steward

Steward American Academy of Ophthalmology

Contact Not Available

Measure Developer Not Available

Development Stage Not Available

Characteristics

Measure Type Process

Meaningful Measure Area Not Available

Healthcare Priority Making Quality Care More Affordable eCQM Spec Available Not Available

NQF Endorsement Status Not Endorsed

NQF ID 9999

Last NQF Update Not Available

Target Population Age 18+

Target Population Age (High) Not Available

Target Population Age (Low) 18

Reporting Level Not Available

Conditions Not Available

Subconditions Not Available

Care Settings Not Available

Report Generated: Wed Sep 29 23:15:41 EDT 2021 | Page 3

Avoidance of routine antibiotic use for patients before or after intravitreal injection

Groups

Core Measure Set Not Available

Measure Links

Measure Program: Merit-Based Incentive Payment System (MIPS) Program

Info As Of Not Available

Program / Model Notes

Data Sources Claims Data

Purposes Not Available

Quality Domain Not Available

Reporting Frequency Not Available

Impacts Payment Not Available

Reporting Status Inactive

Data Reporting Begin Date Not Available

Data Reporting End Date 2017-12-01

Measure Program Links https://qpp.cms.gov/mips/overview

Report Generated: Wed Sep 29 23:15:41 EDT 2021 | Page 4

Avoidance of routine antibiotic use for patients before or after intravitreal injection

Milestones

Milestone: Declined

Effective Date 2017-12-01

Comments Not Available

Other Data Name Value

MUC ID MUC2017-292

Report Generated: Wed Sep 29 23:15:41 EDT 2021 | Page 5